Biogenerics | The World Is Not Waiting for the U.S. to Decide on Regulations
Very few biogeneric drugs have approved in the United States, and few others are on the horizon. Yet they are almost routinely approved and used in the European Union, India and several other countries for the last few years. Why is that and what has to happen so the U.S. can catch up with the rest of the world?
Give the Dog a Shot | Vaccination Changes Bring New Opportunities for Drug Makers and Veterinarians
Until recently, veterinarians and owners commonly administered vaccines to all companion dogs annually for several infectious diseases. In 2005, however, the American Animal Hospital Association’s Canine Vaccine Task Force agreed on a new vaccine protocol based on scientific evidence suggesting that annual vaccinations are unnecessary. What would the financial impact be on veterinarians and vaccine manufacturers? An examination of patent literature since 2006 offers some insight into how pharmaceutical companies have shifted their focus.
